Literature DB >> 22983778

Temporary elimination of orthostatic hypotension by norepinephrine infusion.

David S Goldstein1, LaToya Sewell, Courtney Holmes, Sandra Pechnik, André Diedrich, David Robertson.   

Abstract

A cardinal manifestation of chronic autonomic failure is neurogenic orthostatic hypotension (OH), which often is associated with supine hypertension, posing a therapeutic dilemma. We report here success in a first step toward development of a "prosthetic baroreceptor system" to maintain blood pressure during orthostasis without worsening supine hypertension. In all of four patients with neurogenic OH, titrated i.v. NE infusion kept directly recorded intra-arterial pressure at or above baseline during progressive head-up tilt. We conclude that titrated i.v. NE infusion temporarily eliminates OH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983778      PMCID: PMC4118053          DOI: 10.1007/s10286-012-0176-4

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  10 in total

1.  Ambulatory norepinephrine infusion in severe idiopathic orthostatic hypotension (Bradbury Eggleston syndrome)

Authors:  O Oldenburg; R Erbel; E Fritschka; T Philipp; A Kribben
Journal:  Cardiovasc Drugs Ther       Date:  1999-07       Impact factor: 3.727

2.  Improvement of the exercise capacity of a patient with primary orthostatic hypotension (primary sympathetic insufficiency) by programmed subcutaneous noradrenaline administration via microdosing pump.

Authors:  M Lehmann; K G Petersen; A N Khalaf; D Häussinger; C Büchner; M Sellinger; K Peter
Journal:  Klin Wochenschr       Date:  1990-09-03

3.  Ambulatory norepinephrine treatment of severe autonomic orthostatic hypotension.

Authors:  O Oldenburg; A Mitchell; J Nürnberger; S Koeppen; R Erbel; T Philipp; A Kribben
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

Review 4.  Autonomic failure in neurodegenerative disorders.

Authors:  Horacio Kaufmann; Italo Biaggioni
Journal:  Semin Neurol       Date:  2003-12       Impact factor: 3.420

5.  Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.

Authors:  C Holmes; G Eisenhofer; D S Goldstein
Journal:  J Chromatogr B Biomed Appl       Date:  1994-03-04

6.  Sympathetic neural prosthesis for managing orthostatic hypotension.

Authors:  R J Polinsky; G M Samaras; I J Kopin
Journal:  Lancet       Date:  1983-04-23       Impact factor: 79.321

7.  Estimation of intrasynaptic norepinephrine concentrations in humans.

Authors:  D S Goldstein; R Zimlichman; R Stull; H R Keiser; I J Kopin
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

8.  Sympathetic autonomic dysfunction. Programmed subcutaneous noradrenaline administration via microdosing pump.

Authors:  M Lehmann; K G Petersen; A N Khalaf
Journal:  Klin Wochenschr       Date:  1991-11-26

9.  Ambulatory infusion of noradrenaline for long-term treatment of Shy-Drager syndrome.

Authors:  A Kribben; C Bremer; E Fritschka; S Koeppen; O Ahrens; T Philipp
Journal:  Kidney Blood Press Res       Date:  1998       Impact factor: 2.687

10.  Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.

Authors:  J M Senard; P Valet; G Durrieu; M Berlan; M A Tran; J L Montastruc; A Rascol; P Montastruc
Journal:  Eur J Clin Invest       Date:  1990-12       Impact factor: 4.686

  10 in total
  3 in total

Review 1.  Management of neurogenic orthostatic hypotension in patients with autonomic failure.

Authors:  Christoph Schroeder; Jens Jordan; Horacio Kaufmann
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

Review 2.  Homeostatic systems, biocybernetics, and autonomic neuroscience.

Authors:  David S Goldstein; Irwin J Kopin
Journal:  Auton Neurosci       Date:  2017-09-05       Impact factor: 3.145

3.  Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment options.

Authors:  Ashley L Wagoner; Hossam A Shaltout; John E Fortunato; Debra I Diz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-11-25       Impact factor: 4.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.